The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

The New York State Department of Health on Tuesday confirmed its first case of the new mpox strain, adding to the global concerns over the spread of the little-known variant. According to the U.S.